A study co-led by a University of California, Riverside, biomedical scientist has identified new targets for coronavirus antiviral drugs, including treatments that may be less vulnerable to the rapid evolution of these viruses.
Anonymous readers can preview up to 1024 characters here. Log in to unlock the full article once ingest succeeds.
